LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. (24th June 2018) - Shitara, K; Özgüroğlu, M; Bang, Y J; Di Bartolomeo, M; Mandalà, M; Ryu, M H; Fornaro, L; Olesiński, T; Caglevic, C; Chung, H; Muro, K; Gökkurt, E; et al.